Hydroxyamine

Hydroxyamine

SCHEMBL344671

NO.c1ccc2c(c1)C2

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyamine SCHEMBL268551 0.97 CYP1A2 (0.50)
SCHEMBL29881712 0.89
SCHEMBL22081972 0.89 CYP1A2 (0.62)
SCHEMBL1525601 0.89
SCHEMBL109650 0.89 CYP1A2 (0.62)
SCHEMBL9620436 0.86
Hydrazine SCHEMBL7478669 0.86 CYP1A2 (0.53)
Methylamine SCHEMBL3915422 0.86
SCHEMBL9521460 0.86
Hydrazine SCHEMBL6573930 0.86 CYP1A2 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025020810-A1 ETCHING RESIDUE REMOVER COMPOSITION 安集微电子科技(上海)股份有限公司 2025-01-30 WO claimed
CN-119080751-A Heterocyclic aza-diketone derivative and preparation method and application thereof 山东大学 2024-12-06 CN claimed
CN-117946686-A Composition for selectively etching aluminum oxide 安集微电子科技(上海)股份有限公司 2024-04-30 CN claimed
WO-2024083020-A1 COMPOSITION FOR SELECTIVELY ETCHING ALUMINUM OXIDE 安集微电子科技(上海)股份有限公司 2024-04-25 WO claimed
CN-112714796-A Method for amplifying bisulfite-treated DNA 芝加哥大学 2021-04-27 CN claimed
US-9422233-B2 Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-08-23 US claimed
US-20120252891-A1 Vanilloid Fatty Hydroxamates as Therapeutic Anti-inflammatory Pharmaceuticals UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-10-04 US claimed
EP-1633348-B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARM INC (US) 2008-10-08 EP claimed
CN-101245035-A Hydroxamic acid derivant, preparation method and antineoplastic application KUNMING INST BOTANY CN ACAD (CN) 2008-08-20 CN claimed
CN-122055358-A GPR65 small molecule regulator and preparation method and application thereof 四川大学 2026-05-15 CN disclosed
US-20250312467-A1 COMPOUND FOR PREPARATION OF ANTIBODY-PAYLOAD CONJUGATE AND USE THEREOF Research & Business Foundation Sungkyunkwan University (KR) 2025-10-09 US disclosed
US-12415797-B2 Heterocyclic compound as CDK-HDAC double-channel inhibitor HANGZHOU INNOGATE PHARMA CO., LTD. (CN) 2025-09-16 US disclosed
EP-3350333-B2 POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION MODERNATX INC (US) 2025-08-06 EP disclosed
US-20250199006-A1 METHOD FOR DIAGNOSING CANCER FUNDACIO INST MAR DINVESTIGACIONS MEDIQUES IMIM (ES) 2025-06-19 US disclosed
EP-0091385-B1 PROCESS FOR THE PREPARATION OF P-HYDROXYBENZYL NITRILES OR P-HYDROXYBENZYL AMINES RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-06-12 EP disclosed
EP-0051381-B1 O-SULFATED BETA-LACTAM HYDROXAMIC ACIDS E.R. Squibb &amp; Sons, Inc. (US) 1985-01-30 EP disclosed
EP-0091385-A1 Process for the preparation of p-hydroxybenzyl nitriles or p-hydroxybenzyl amines RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-12 EP disclosed
US-4337197-A BACTERICIDES E. R. SQUIBB & SONS, INC. (US) 1982-06-29 US disclosed
EP-0051381-A1 O-sulfated beta-lactam hydroxamic acids E.R. Squibb &amp; Sons, Inc. (US) 1982-05-12 EP disclosed
US-4173647-A ANTIMICROBIAL BOEHRINGER INGELHEIM GMBH (DE) 1979-11-06 US disclosed